Arrowstreet Capital
MDXG icon

Arrowstreet Capital’s MiMedx Group MDXG Stock Holding History

Arrowstreet Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Buy
1,266,571
+490,730
+63% +$1.79M ﹤0.01% 1292
2026
Q1 		$3.06M Buy
775,841
+146,683
+23% +$739K ﹤0.01% 1296
2025
Q4 		$4.26M Buy
629,158
+445,755
+243% +$3.12M ﹤0.01% 1182
2025
Q3 		$1.28M Buy
183,403
+84,440
+85% +$587K ﹤0.01% 1541
2025
Q2 		$605K Sell
98,963
-2,298
-2% -$15.3K ﹤0.01% 1710
2025
Q1 		$770K Sell
101,261
-261,220
-72% -$2.18M ﹤0.01% 1530
2024
Q4 		$3.49M Buy
362,481
+300,433
+484% +$2.34M ﹤0.01% 1120
2024
Q3 		$367K Sell
62,048
-841,096
-93% -$5.57M ﹤0.01% 1566
2024
Q2 		$6.26M Sell
903,144
-27,005
-3% -$190K 0.01% 770
2024
Q1 		$7.16M Buy
930,149
+7,554
+0.8% +$60.7K 0.01% 786
2023
Q4 		$8.09M Buy
922,595
+254,032
+38% +$1.86M 0.01% 614
2023
Q3 		$4.87M Buy
668,563
+444,072
+198% +$3.31M 0.01% 663
2023
Q2 		$1.48M Buy
+224,491
New +$1.14M ﹤0.01% 900
2021
Q1 		– Sell
-457,760
Closed -$4.16M – 2411
2020
Q4 		$4.16M Buy
+457,760
New +$3.3M 0.01% 1281
2018
Q4 		– Sell
-1,377,884
Closed -$8.52M – 1439
2018
Q3 		$8.52M Sell
1,377,884
-293,160
-18% -$1.32M 0.02% 440
2018
Q2 		$10.7M Sell
1,671,044
-55,511
-3% -$395K 0.03% 405
2018
Q1 		$12M Buy
1,726,555
+1,093,038
+173% +$12.7M 0.03% 407
2017
Q4 		$7.99M Buy
633,517
+360,717
+132% +$4.4M 0.02% 502
2017
Q3 		$3.24M Buy
272,800
+262,300
+2,498% +$3.89M 0.01% 581
2017
Q2 		$157K Buy
+10,500
New +$140K ﹤0.01% 1013

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Arrowstreet Capital's MDXG Position: Q2 2026 in Review

Arrowstreet Capital increased its MiMedx Group (MDXG) stake by 63% in Q2 2026, buying an estimated $1.79M and bringing the position to 1,266,571 shares worth $4.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Arrowstreet Capital first reported a position in MDXG in Q2 2017 and has held it in 20 quarters since. The position peaked at $12M in Q1 2018. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Arrowstreet Capital held 1,266,571 shares of MiMedx Group worth $4.88M as of Q2 2026.
  • Arrowstreet Capital bought 490,730 MiMedx Group shares in Q2 2026, an estimated $1.79M.
  • MiMedx Group made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1292 holding.
  • Arrowstreet Capital first reported a position in MiMedx Group in Q2 2017 and has held it in 20 quarters since.
  • Arrowstreet Capital's MiMedx Group position peaked at $12M in Q1 2018.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.